Press release
Investigation announced for former Investors in formerly Avedro, Inc. (Nasdaq: AVDR , now Glaukos Corporation (NYSE: GKOS)
An investigation for investors in formerly Avedro, Inc. (Nasdaq: AVDR), now Glaukos Corporation (NYSE: GKOS) shares.
Investors who held Avedro, Inc. (Nasdaq: AVDR) shares and received shares of Glaukos Corporation (NYSE: GKOS) have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm concerns whether certain officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.
San Clemente, CA based Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma.
On August 7, 2019, Avedro, Inc’s Board of Directors caused the Company to enter into an agreement and plan of merger with Glaukos. Pursuant to the terms of the Merger Agreement, Avedro, Inc’s stockholders will receive 0.365 shares of Glaukos Corporation (NYSE: GKOS common stock for each share of Avedro, Inc. (Nasdaq: AVDR) common stock they own.
In November 2019, Glaukos Corporation (NYSE: GKOS) completed its merger with Avedro, Inc. (Nasdaq: AVDR).
Shares of Glaukos Corporation (NYSE: GKOS) declined from $75 per share in July 2019 to as low as $23.31 per share in March 2020.
Those who purchased shares of Glaukos Corporation (NYSE: GKOS) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Investigation announced for former Investors in formerly Avedro, Inc. (Nasdaq: AVDR , now Glaukos Corporation (NYSE: GKOS) here
News-ID: 2186871 • Views: …
More Releases from Shareholders Foundation
Lawsuit for Investors in Sonder Holdings Inc. (NASDAQ: SOND) filed in effort to …
An investor, who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND), filed a lawsuit over alleged violations of Federal Securities Laws by Sonder Holdings Inc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of Sonder Holdings Inc. (NASDAQ: SOND) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: SOND investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com…
Lawsuit filed for Investors in Ocugen, Inc. (NASDAQ: OCGN) in effort to recover …
An investor, who purchased shares of Ocugen, Inc. (NASDAQ: OCGN), filed a lawsuit i over alleged violations of Federal Securities Laws by Ocugen, Inc..
Investors who purchased shares of Ocugen, Inc. (NASDAQ: OCGN) have certain options and for certain investors are short and strict deadlines running. Deadline: June 10, 2024. NASDAQ: OCGN investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
Malvern, PA based Ocugen, Inc., a…
Investors who lost money with shares of Evolv Technologies Holdings, Inc. (NASDA …
An investor, who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Evolv Technologies Holdings, Inc. f/k/a NewHold Investment Corp.
Investors who purchased shares of Evolv Technologies Holdings, Inc. (NASDAQ: EVLV) have certain options and for certain investors are short and strict deadlines running. Deadline: May 24, 2024. NASDAQ: EVLV…
Investigation announced for Investors who purchased shares of Comtech Telecommun …
Comtech Telecommunications Corp is under investigation over potential securities laws violations in connection with certain financial statements.
Investors who purchased shares of Comtech Telecommunications Corp. (NASDAQ: CMTL), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on whether a series of statements by Comtech Telecommunications Corp. regarding its business, its prospects and its operations were materially false…
More Releases for Glaukos
Glaucoma Surgery Devices Market Report- Growth with Top Key Vendors like- Glauko …
The Glaucoma Surgery Devices Market research report presents an intensive and coordinated exploration of the current circumstance, Glaucoma Surgery Devices Market key elements, market methodologies, and central participants' development in the business. The investigation helps controllers and corporate leaders in developing cost-effective decisions. Glaucoma Surgery Devices Market provides an evenhanded and extensive assessment of existing examples, factors, obstacles, limits, headway, possibilities/quick development areas that will help partners create business plans…
Global Ophthalmic Devices Market | Clearlab SG PTE, Ltd. EssilorLuxottica SA Gla …
Global Ophthalmic Devices Market Report published by Astute Analytica provides insight and updates about the corresponding segments involved in the global market for the forecast period of 2021-2027. A detailed analysis of the market dynamics is provided and comprehensive data about the structure of the industry. The Global Ophthalmic Devices Market Research Study contains exclusive insights into the market's forecast growth.
Global Ophthalmic Devices Market is expected to witness market growth…
Glaucoma Surgery Devices Market Trends, Review, and Forecast by 2026 | Abbott La …
Glaucoma Surgery Devices Market
Glaucoma surgery devices are expected to gain momentum in the future since they serve an important role in treating glaucoma. The primary goal of these devices is to attain intraocular pressure stabilisation or decrease (IOP). Because of the necessity for quicker glaucoma treatment to avoid vision loss, the need for effective glaucoma surgical technologies is constantly increasing. High incidence of glaucoma across the world, as well as…
Glaukos Corporation (NYSE: GKOS) Investor Notice: Investigation for former Avedr …
An investigation on behalf of investors of former Avedro, Inc. (Nasdaq: AVDR),who received shares of Glaukos Corporation (NYSE: GKOS) over potential securities laws violations in connection with certain statements.
Investors who purchased shares of Glaukos Corporation (NYSE: GKOS), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm focuses on concerning whether certain statements by Glaukos Corporation regarding…
Gel Stent Market Key companies Profile Allergan, Alcon, Innfocus and Glaukos Cor …
Stent is a small expandable tube used for the treatment of narrowed arteries. It is used to prevent bursting of arteries and improve blood flow of weak arteries. Soft gelatin is used for the preparation of gel stent. When gel stent is injected, it gets hydrated and drains the aqueous humor in the sub-conjunctival space, which lowers the intraocular pressure. This procedure is minimally invasive.
Gel Stent Market – Dynamics
Rising population…
Gel Stent Market Evolving Technology, Trends and Top Players Allergan, Alcon, In …
Stent is a small expandable tube used for the treatment of narrowed arteries. It is used to prevent bursting of arteries and improve blood flow of weak arteries. Soft gelatin is used for the preparation of gel stent. When gel stent is injected, it gets hydrated and drains the aqueous humor in the sub-conjunctival space, which lowers the intraocular pressure. This procedure is minimally invasive.
Gel Stent Market – Dynamics
Rising population…
